{"nctId":"NCT04056325","briefTitle":"Efficacy, Safety, and PK of Ascending Dosages of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis","startDateStruct":{"date":"2019-11-27","type":"ACTUAL"},"conditions":["Strongyloides Stercoralis Infection"],"count":617,"armGroups":[{"label":"Phase 2a - Arm A","type":"EXPERIMENTAL","interventionNames":["Drug: Moxidectin"]},{"label":"Phase 2a - Arm B","type":"EXPERIMENTAL","interventionNames":["Drug: Moxidectin"]},{"label":"Phase 2a - Arm C","type":"EXPERIMENTAL","interventionNames":["Drug: Moxidectin"]},{"label":"Phase 2a - Arm D","type":"EXPERIMENTAL","interventionNames":["Drug: Moxidectin"]},{"label":"Phase 2a - Arm E","type":"EXPERIMENTAL","interventionNames":["Drug: Moxidectin"]},{"label":"Phase 2a - Arm F","type":"EXPERIMENTAL","interventionNames":["Drug: Moxidectin"]},{"label":"Phase 2a - Arm G","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo oral tablet"]},{"label":"Phase 2b - Arm A","type":"EXPERIMENTAL","interventionNames":["Drug: Moxidectin"]},{"label":"Phase 2b - Arm B","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Ivermectin"]}],"interventions":[{"name":"Moxidectin","otherNames":[]},{"name":"Ivermectin","otherNames":[]},{"name":"Placebo oral tablet","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Adults (â‰¥ 18 years) infected with S. stercoralis\n* Absence of major systemic illnesses\n* Written informed consent signed by individual\n\nExclusion Criteria:\n\n* Any abnormal medical conditions or chronic disease\n* Negative diagnostic result for S. stercoralis\n* No written informed consent by individual.\n* Pregnant and lactating women.\n* Recent use of anthelmintic drug (within past 4 weeks), attending other clinical trials during the study\n* Known allergy to study medications (i.e. moxidectin, ivermectin)\n* Currently taking medications with known interaction (i.e. for warfarin)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"60 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Observed Cure Rate Against Strongyloides Stercoralis","description":"The conversion from being larvae positive pre-treatment to larvae negative post-treatment, or cure rate (CR).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"73.3","spread":null},{"groupId":"OG001","value":"89.7","spread":null},{"groupId":"OG002","value":"84.4","spread":null},{"groupId":"OG003","value":"82.8","spread":null},{"groupId":"OG004","value":"96.6","spread":null},{"groupId":"OG005","value":"87.1","spread":null},{"groupId":"OG006","value":"13.8","spread":null},{"groupId":"OG007","value":"92.7","spread":null},{"groupId":"OG008","value":"92.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Observed Larvae-reduction Rate (LRR) Against Strongyloides Stercoralis","description":"Larvae per gram (LPG) stool sample will be assessed by calculating the mean of the larvae counts from the three duplicate Baermann assays and divided by the mean weighted amount of these stool samples. The LRR will be calculated following: (LRR = (1-(mean at follow-up/mean at baseline))\\*100)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"98.4","spread":null},{"groupId":"OG001","value":"99.4","spread":null},{"groupId":"OG002","value":"99.8","spread":null},{"groupId":"OG003","value":"97.8","spread":null},{"groupId":"OG004","value":"98.6","spread":null},{"groupId":"OG005","value":"98.5","spread":null},{"groupId":"OG006","value":"27.0","spread":null},{"groupId":"OG007","value":"99.6","spread":null},{"groupId":"OG008","value":"99.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Observed CRs Against Concomitant Soil-transmitted Helminth Infections - Ascaris Lumbricoides","description":"CRs will be calculated for Ascaris lumbricoides infections as described in primary outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"100","spread":null},{"groupId":"OG003","value":"100","spread":null},{"groupId":"OG004","value":"100","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG007","value":"100","spread":null},{"groupId":"OG008","value":"83.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Observed CRs Against Concomitant Soil-transmitted Helminth Infections - Trichuris Trichiura","description":"CRs will be calculated for Trichuris trichiura infections as described in primary outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null},{"groupId":"OG001","value":"100","spread":null},{"groupId":"OG002","value":"50","spread":null},{"groupId":"OG003","value":"33","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"100","spread":null},{"groupId":"OG008","value":"100","spread":null}]}]}]},{"type":"SECONDARY","title":"Observed CRs Against Concomitant Soil-transmitted Helminth Infections - Hookworm","description":"CRs will be calculated for Hookworm infections as described in primary outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"11","spread":null},{"groupId":"OG002","value":"14","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"10","spread":null},{"groupId":"OG005","value":"29","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"31.9","spread":null},{"groupId":"OG008","value":"17.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Reporting Adverse Events","description":"Subjects will be kept for observation for at least 3 hours following treatment for any acute AEs. If there is any abnormal finding, the local study physician will perform a full clinical, physical and biochemical examination and findings will be recorded. An emergency kit will be available on site to treat any medical conditions that warrant urgent medical intervention. In addition patients will also be interviewed 2-3 and 24 hours and again 3-4 (phase 2a) or 2-3 (phase 2b) weeks after treatment about the occurrence of AEs. A standardized symptom questionnaire is used, that includes the recording of headache, abdominal pain, itching, nausea, vomiting, diarrhea, allergic reaction as well as any further mentioned event by the participant.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"1","spread":null},{"groupId":"OG003","value":"1","spread":null},{"groupId":"OG004","value":"2","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"5","spread":null},{"groupId":"OG007","value":"11","spread":null},{"groupId":"OG008","value":"9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"2","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"1","spread":null},{"groupId":"OG007","value":"12","spread":null},{"groupId":"OG008","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"1","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"1","spread":null},{"groupId":"OG007","value":"2","spread":null},{"groupId":"OG008","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"1","spread":null},{"groupId":"OG007","value":"3","spread":null},{"groupId":"OG008","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"0","spread":null},{"groupId":"OG008","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"0","spread":null},{"groupId":"OG008","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"0","spread":null},{"groupId":"OG008","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"1","spread":null},{"groupId":"OG007","value":"7","spread":null},{"groupId":"OG008","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"21","spread":null},{"groupId":"OG008","value":"21","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"5","spread":null},{"groupId":"OG008","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"3","spread":null},{"groupId":"OG008","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"7","spread":null},{"groupId":"OG008","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"1","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"1","spread":null},{"groupId":"OG007","value":"0","spread":null},{"groupId":"OG008","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"1","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"0","spread":null},{"groupId":"OG008","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"1","spread":null},{"groupId":"OG003","value":"2","spread":null},{"groupId":"OG004","value":"2","spread":null},{"groupId":"OG005","value":"1","spread":null},{"groupId":"OG006","value":"2","spread":null},{"groupId":"OG007","value":"8","spread":null},{"groupId":"OG008","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"12","spread":null},{"groupId":"OG008","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"9","spread":null},{"groupId":"OG008","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"2","spread":null},{"groupId":"OG008","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"1","spread":null},{"groupId":"OG007","value":"0","spread":null},{"groupId":"OG008","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"1","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"2","spread":null},{"groupId":"OG008","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"0","spread":null},{"groupId":"OG008","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Maximum Concentration (Cmax) of Moxidectin in Adults","description":"Upon oral intake moxidectin levels in blood will be quantified with time using a micro sampling device. Moxidectin will be quantified using a validated liquid chromatography tandem mass spectrometry (LC-MS/MS) method. Drug concentrations will be calculated by interpolation from a calibration curve with a foreseen limit of quantification of approximately 5 ng/ml. The PK analysis will be undertaken fitting a structural compartmental PK model.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"86.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Reach Cmax (Tmax) of Moxidectin in Adults","description":"Upon oral intake moxidectin levels in blood will be quantified with time using a micro sampling device. Moxidectin will be quantified using a validated liquid chromatography tandem mass spectrometry (LC-MS/MS) method. Drug concentrations will be calculated by interpolation from a calibration curve with a foreseen limit of quantification of approximately 5 ng/ml. The PK analysis will be undertaken fitting a structural compartmental PK model.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Area Under the Curve (AUC) of Moxidectin in Adults","description":"Upon oral intake moxidectin levels in blood will be quantified with time using a micro sampling device. Moxidectin will be quantified using a validated liquid chromatography tandem mass spectrometry (LC-MS/MS) method. Drug concentrations will be calculated by interpolation from a calibration curve with a foreseen limit of quantification of approximately 5 ng/ml. The PK analysis will be undertaken fitting a structural compartmental PK model.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"5028","spread":null}]}]}]},{"type":"SECONDARY","title":"Elimination Half Life (T1/2) of Moxidectin in Adults","description":"Upon oral intake moxidectin levels in blood will be quantified with time using a micro sampling device. Moxidectin will be quantified using a validated liquid chromatography tandem mass spectrometry (LC-MS/MS) method. Drug concentrations will be calculated by interpolation from a calibration curve with a foreseen limit of quantification of approximately 5 ng/ml. The PK analysis will be undertaken fitting a structural compartmental PK model.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"666","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":31},"commonTop":["Abdominal pain","Headache","Itching","Vomiting","Diarrhea"]}}}